pMD18-T Simple Vector is a high-efficiency TA cloning vector constructed from pUC18, of which the initial multiple cloning sites (MCS) were destroyed. Thus the cDNA should be amplified by PCR with primers containing a restriction site for subclone. Competent cells appropriate for pUC18 are also appropriated for the Vector, e.g. JM109, DH5α, TOP10. The pMD18-T Simple Vector is 2.6kb in size. Selection of the plasmid in E. coli is conferred by the ampicillin resistance gene. The coding sequence was inserted by TA cloning at site 425.
The coding sequence can be amplified by PCR with M13-47 and RV-M primers.
|Human IGFBP3 ORF mammalian expression plasmid, C-GFPSpark tag||HG10430-ACG|
|Human IGFBP3 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||HG10430-ACR|
|Human IGFBP3 ORF mammalian expression plasmid, C-Flag tag||HG10430-CF|
|Human IGFBP3 ORF mammalian expression plasmid, C-His tag||HG10430-CH|
|Human IGFBP3 ORF mammalian expression plasmid, C-Myc tag||HG10430-CM|
|Human IGFBP3 ORF mammalian expression plasmid, C-HA tag||HG10430-CY|
|Human IGFBP3 ORF mammalian expression plasmid, N-Flag tag||HG10430-NF|
|Human IGFBP3 ORF mammalian expression plasmid, N-His tag||HG10430-NH|
|Human IGFBP3 ORF mammalian expression plasmid, N-Myc tag||HG10430-NM|
|Human IGFBP3 ORF mammalian expression plasmid, N-HA tag||HG10430-NY|
|Human IGFBP3 natural ORF mammalian expression plasmid||HG10430-UT|
|Learn more about expression Vectors|
The Insulin-like Growth Factor (IGF) signaling system plays a central role in cellular growth, differentiation and proliferation. IGFBP3 is the most abundant IGF binding protein in human serum and has been shown to be a growth inhibitory, apoptosis-inducing molecule, capable of acting via IGF-dependent and IGF-independent mechanisms. It appears to function both by cell cycle blockade and the induction of apoptosis. IGFBP3 can be transported to the nucleus by an importin beta mediated mechanism, where it has been shown to interact with the retinoid X receptor alpha and possibly other nuclear elements. IGFBP3 antiproliferative signalling appears to require an active transforming growth factor beta (TGF-beta) signalling pathway, and IGFBP3 stimulates phosphorylation of the TGF-beta signalling intermediates Smad2 and Smad3. IGFBP3 has IGF-independent roles in inhibiting cell proliferation in cancer cell lines. Nuclear transcription factor, retinoid X receptor (RXR)-alpha, and IGFBP3 functionally interact to reduce prostate tumor growth and prostate-specific antigen in vivo. Several clinical studies have proposed that individuals with IGFBP3 levels in the upper range of normal may have a decreased risk for certain common cancers. This includes evidence of a protective effect against breast cancer, prostate cancer, colorectal cancer, and lung cancer. Moreover, IGFBP3 inhibits insulin-stimulated glucose uptake into adipocytes independent of IGF.